Milestone Scientific Number Of Shares Shorted vs. Current Valuation
| MLSS Stock | USD 0.28 -0.02 -6.67% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.46 | 0.67 |
|
|
This view for Milestone Scientific frames profitability through return on assets, equity, and margin metrics. Profitability data is presented without directional implication.
Milestone | Build portfolio with Milestone Stock |
Macro event markers
Earnings Share -0.09 | Revenue Per Share | Quarterly Revenue Growth -0.06 | Return On Assets | Return On Equity |
Milestone Scientific's market capitalization and book value each provide useful but distinct information about the business. Milestone Scientific's market capitalization is 23.58 M. With a P/B ratio of 9.25, the market values Milestone Scientific well above its book equity. Enterprise value stands at 23.29 M. The relationship between Milestone Scientific's intrinsic value, market price, and book value adds depth to the analysis.
Distinguishing between Milestone Scientific's value and market price helps frame analytical expectations. In practice, Milestone Scientific price is set by the continuous auction process on its listing exchange.
Milestone Scientific Current Valuation vs. Number Of Shares Shorted Fundamental Analysis
Valuation ratios compare Milestone Scientific to competitors to determine relative overvaluation or discount. Milestone Scientific is rated below average in number of shares shorted relative to competitors. It is rated below average in current valuation relative to competitors yielding 181.78 of Current Valuation per Number Of Shares Shorted. Sector multiples frame Milestone Scientific's current valuation context.Milestone Current Valuation vs. Number Of Shares Shorted
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Milestone Scientific |
| = | 128.12 K |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account all liquid assets, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Milestone Scientific |
| = | 23.29 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Milestone Current Valuation vs Competition
Milestone Scientific is rated below average in current valuation relative to competitors. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 561.26 Million. Milestone Scientific holds roughly 23.29 Million in current valuation claiming about 4% of equities under Health Care sector.
Milestone Scientific Profitability Projections
Milestone Scientific's ability to earn and keep profits over time is one of the most direct signs of business quality. Checking Milestone Scientific's current margins against past averages shows if profits are trending the right way. Milestone Scientific currently maintains a profit margin of -74.7%. The gap between gross and net margins shows how much of Milestone Scientific's revenue goes to overhead and debt costs. The operating margin stands at -48.1% while return on equity is -136.5%.
| Last Reported | End Of Year Estimate | ||
| Operating Income | -6.1 M | -6.4 M | |
| Income Before Tax | -4.2 M | -4.5 M | |
| Total Other Income Expense Net | 1.8 M | 1.9 M | |
| Net Loss | -4.2 M | -4.5 M | |
| Income Tax Expense | -46.7 K | -44.3 K | |
| Net Loss | -4.2 M | -4.5 M | |
| Non Operating Income Net Other | 65.8 K | 69.1 K | |
| Net Loss | -6.1 M | -6.4 M | |
| Interest Income | 7.7 K | 5.5 K | |
| Net Interest Income | 69.3 K | 72.8 K | |
| Change To Netincome | 1.9 M | 2.1 M | |
| Net Loss | -0.05 | -0.06 | |
| Income Quality | 0.71 | 0.57 | |
| Net Income Per E B T | 1.14 | 1.18 |
Milestone Profitability Driver Comparison
Profitability drivers are a critical input for any investor evaluating Milestone Scientific's long-term potential. While many factors affecting Milestone Scientific's earnings are unpredictable, tracking key indicators provides a useful framework.
Earnings per Share Projection vs Actual
Use Milestone Scientific in pair-trading
Using Milestone Scientific in a pair-trading setup can improve risk control because gains and losses are judged against a second position instead of against the market alone. This framework is most useful when investors want to hedge directional moves caused by sector headlines or broad market pressure.
Milestone Scientific Pair Trading
Milestone Scientific Pair Trading Analysis
Finding correlated alternatives to Milestone Scientific is a practical necessity for tax-aware investors. Holding a correlated substitute during the wash-sale period minimizes portfolio drift from Milestone Scientific.
The statistical relationship between Milestone Scientific and other instruments is summarized by the correlation coefficient. Assets with correlations below 0.3 to Milestone Scientific typically offer meaningful diversification benefits.
Correlation analysis and pair evaluation for Milestone Scientific can support hedging context. The reliability of pair-based hedging varies with market conditions and correlation stability.Use Investing Themes to Complement your Milestone Scientific position
Milestone Scientific operates in Healthcare/Medical Instruments & Supplies at 23.58 Million market cap - a thematic view expands this smaller-cap position into a broader portfolio concept. For Milestone Scientific in Medical Instruments & Supplies, the theme workflow defines the investment thesis first, then optimizes which Healthcare assets best express that view at the smaller-cap level.
Did You Try This Idea?
Run Restaurants Thematic Idea Now
Restaurants
Entities that are involved in restaurant business, as well as coffee shop chains and other eateries. The Restaurants theme has 34 constituents at this time.
Whether used as a passive allocation or an active trading idea, the Restaurants Theme provides a structured starting point for portfolio construction.
| View All Next | Launch |
Additional Tools for Milestone Stock Analysis
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Prophet Use AI to generate optimal portfolios and find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |